Literature DB >> 19303395

Identification and characterization of flavonoids as sialyltransferase inhibitors.

Kazuya I P J Hidari1, Kin-ichi Oyama, Go Ito, Miho Nakayama, Makoto Inai, Shiho Goto, Yugo Kanai, Kei-ichi Watanabe, Kumi Yoshida, Takumi Furuta, Toshiyuki Kan, Takashi Suzuki.   

Abstract

Sialyltransferases biosynthesize sialyl-glycoconjugates involved in many biological and pathological processes. We investigated and characterized synthetic flavonoid derivatives as sialyltransferase inhibitors. We first examined 54 compounds by solid-phase enzyme assay using beta-galactoside alpha2,6-sialyltransferase 1 (ST6Gal I) and beta-galactoside alpha2,3-sialyltransferase. Several compounds inhibited sialyltransferase enzyme activity regardless of sialyl-linkage reactions. Among them, two compounds showed inhibitory activity against ST6Gal I with IC(50) values less than 10 microM. Three characteristic features of flavonoids were determined by structure-inhibitory activity relationships. First, a double bond between C2-C3 linkages is required for the activity. Second, increasing hydrophilic properties on the B-ring markedly augmented the inhibitory effect. Third, a hydrophobic functional group introduced on the hydroxyl groups of the A-ring enhanced the inhibitory activity. Kinetic analysis using human ST6Gal I indicated a mixed inhibition mechanism of the compounds. In conclusion, the flavonoids identified could be applied for control of cellular expression of sialic acid.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19303395     DOI: 10.1016/j.bbrc.2009.03.082

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Biotransformation of Flavonoid Conjugates with Fatty Acids and Evaluations of Their Functionalities.

Authors:  Cynthia Q Sun; Keryn D Johnson; Herbert Wong; L Y Foo
Journal:  Front Pharmacol       Date:  2017-11-02       Impact factor: 5.810

Review 2.  Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?

Authors:  Silvia Pietrobono; Barbara Stecca
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

Review 3.  Aberrant Sialylation in Cancer: Therapeutic Opportunities.

Authors:  Jennifer Munkley
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

4.  Glycomic Analysis Reveals That Sialyltransferase Inhibition Is Involved in the Antiviral Effects of Arbidol.

Authors:  Yue Kang; Zhi-Tong Mai; Lee-Fong Yau; Run-Feng Li; Tian-Tian Tong; Chun-Guang Yang; Ka-Man Chan; Zhi-Hong Jiang; Yutao Wang; Zi-Feng Yang; Jing-Rong Wang
Journal:  J Virol       Date:  2022-01-19       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.